Cytokinetics, Incorporated

CYTKNASDAQHealthcare● Active

$69.02

$-2.46(-3.44%)

Market Cap$8.6B

P/E Ratio—

52W High$80.2

52W Low$31.52

Avg Volume2.4M

Open$72.00

Beta0.43

Net Income Financials Revenue

Cytokinetics, Incorporated (CYTK) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

CYTK · net income · updated Jun 8, 2026

Core profitability metrics

CYTK · net income · margin · TTM · CAGR

Net income was −$785.0M for FY2025 (fiscal year ending 2025-12-31), down 33.2% year-over-year. Net profit margin was -891.6%. Based on available data, Cytokinetics, Incorporated has been profitable since at least 2016.

FY2025 Net Income−$785.0M▼ -33.2% YoY

Trailing 12M (TTM)−$829.6Mtrailing 4 quarters sum

Net Profit Margin-891.6%−$785.0M ÷ $88.0M

YoY Change-33.2%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2016

▸ FMP /income-statement · Annual · CYTK net income history · CYTK profit margin

Annual net income data

CYTK · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$785.0M▼ 33.2%-891.6%$88.0M

FY2024Loss−$589.5M▼ 12.0%-3191.1%$18.5M

FY2023Loss−$526.2M▼ 35.3%-6988.6%$7.5M

FY2022Loss−$389.0M▼ 80.6%-411.2%$94.6M

FY2021Loss−$215.3M▼ 69.2%-305.7%$70.4M

Net income vs peers (Healthcare)

CYTK vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Cytokinetics, IncorporatedYOU

CYTK

−$785.0M-33.2%-891.6%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Cytokinetics, Incorporated (CYTK) reported net income of −$785.0M for FY2025 (fiscal year ending 2025-12-31), down 33.2% year-over-year. The net profit margin was -891.6% — meaning the company kept $-8.92 of every dollar of revenue as profit.

Based on available data, Cytokinetics, Incorporated has been profitable since at least 2016. Net income reached a peak of $16.5M in FY2016. Data available for 15 fiscal years.

Cytokinetics, Incorporated's net profit margin was -891.6% for FY2025, based on the latest annual results.

Investors sometimes search for "Cytokinetics, Incorporated net worth" — the company's market capitalization is a separate figure from CYTK net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

CYTK net income · 4 questions

Cytokinetics, Incorporated is not currently profitable on an annual basis. The company reported a net loss of $785.0M for FY2025.

is CYTK profitabledoes CYTK make a profitCYTK profitabilityCYTK profitable company

▸ Source: FMP /income-statement · GAAP · Cytokinetics, Incorporated · Cytokinetics, Incorporated SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026